Tutengcao Granules

Taking "the change in VAS score of joint pain compared with baseline after the end of medication on the 7th day" as the main efficacy indicator, a randomized, double-blind, placebo-controlled, multicenter clinical trial design was adopted to preliminarily evaluate the efficacy and safety of different doses of Tutengcao granules in the treatment of acute gouty arthritis (damp-heat accumulation syndrome), and provide a basis for Phase III clinical research.